Works matching IS 03407004 AND DT 2007 AND VI 56 AND IP 9

Results: 16

Density of DC-LAMP+ mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor.

Published in:

Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1459, doi. 10.1007/s00262-007-0286-3

By:

Ladányi, Andrea;
Kiss, Judit;
Somlai, Beáta;
Gilde, Katalin;
Fejős, Zsuzsanna;
Mohos, Anita;
Gaudi, István;
Tímár, József

Publication type:

Article

Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironment.

Published in:

Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1429, doi. 10.1007/s00262-007-0280-9

By:

Bergmann, Christoph;
Strauss, Laura;
Zeidler, Reinhard;
Lang, Stephan;
Whiteside, Theresa

Publication type:

Article

A new epitope peptide derived from hepatitis C virus 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLA-A11, -A31, and -A33.

Published in:

Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1359, doi. 10.1007/s00262-007-0284-5

By:

Matsueda, Satoko;
Yamada, Akira;
Takao, Yukari;
Tamura, Mayumi;
Komatsu, Nobukazu;
Yutani, Shigeru;
Ide, Tatsuya;
Sata, Michio;
Itoh, Kyogo

Publication type:

Article

Increase in CD30 ligand/CD153 and TNF-α expressing mast cells in basal cell carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1407, doi. 10.1007/s00262-007-0290-7

By:

Diaconu, Nicolae-Costin;
Kaminska, Renata;
Naukkarinen, Anita;
Harvima, Rauno J.;
Nilsson, Gunnar;
Harvima, Ilkka T.

Publication type:

Article

Dendritic cells loaded with polyomavirus VP1/VP2Her2 virus-like particles efficiently prevent outgrowth of a Her2/neu expressing tumor.

Published in:

Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1335, doi. 10.1007/s00262-007-0281-8

By:

Tegerstedt, Karin;
Franzén, Andrea;
Ramqvist, Torbjörn;
Dalianis, Tina

Publication type:

Article

Adoptive therapy of head and neck squamous cell carcinoma with antibody coated immune cells: a pilot clinical trial.

Published in:

Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1397, doi. 10.1007/s00262-007-0283-6

By:

Riechelmann, Herbert;
Wiesneth, Markus;
Schauwecker, Peter;
Reinhardt, Peter;
Gronau, Silke;
Schmitt, Anita;
Schroen, Carsten;
Atz, Judith;
Schmitt, Michael

Publication type:

Article

The Thomsen-Friedenreich disaccharide as antigen for in vivo tumor targeting with multivalent scFvs.

Published in:

Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1345, doi. 10.1007/s00262-007-0292-5

By:

Ravn, Peter;
Stahn, Renate;
Danielczyk, Antje;
Faulstich, Dorian;
Karsten, Uwe;
Goletz, Steffen

Publication type:

Article

Long-term immunity elicited by antibody–cytokine fusion proteins protects against sequential challenge with murine mammary and colon malignancies.

Published in:

Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1507, doi. 10.1007/s00262-007-0297-0

By:

Helguera, Gustavo;
Rodríguez, José;
Daniels, Tracy R.;
Penichet, Manuel L.

Publication type:

Article

Development of anti-PAX3 immune responses; a target for cancer immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1381, doi. 10.1007/s00262-007-0294-3

By:

Himoudi, Nourredine;
Nabarro, Steven;
Yan, Mengyong;
Gilmour, Kimberly;
Thrasher, Adrian J.;
Anderson, John

Publication type:

Article

The combined activation of positive costimulatory signals with modulation of a negative costimulatory signal for the enhancement of vaccine-mediated T-cell responses.

Published in:

Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1471, doi. 10.1007/s00262-007-0291-6

By:

Chakraborty, Mala;
Schlom, Jeffrey;
Hodge, James W.

Publication type:

Article

Reciprocal effects of Th1 and Treg cell inducing pathogen-associated immunomodulatory molecules on anti-tumor immunity.

Published in:

Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1367, doi. 10.1007/s00262-007-0288-1

By:

Lysaght, Joanne;
Jarnicki, Andrew G.;
Mills, Kingston H. G.

Publication type:

Article

Interleukin 21 therapy increases the density of tumor infiltrating CD8+ T cells and inhibits the growth of syngeneic tumors.

Published in:

Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1417, doi. 10.1007/s00262-007-0285-4

By:

Søndergaard, Henrik;
Frederiksen, Klaus S.;
Thygesen, Peter;
Galsgaard, Elisabeth D.;
Skak, Kresten;
Kristjansen, Paul E. G.;
Ødum, Niels;
Kragh, Michael

Publication type:

Article

Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers.

Published in:

Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1485, doi. 10.1007/s00262-007-0293-4

By:

Svane, Inge Marie;
Pedersen, Anders E.;
Johansen, Julia S.;
Johnsen, Hans E.;
Nielsen, Dorte;
Kamby, Claus;
Ottesen, Svend;
Balslev, Eva;
Gaarsdal, Eva;
Nikolajsen, Kirsten;
Claesson, Mogens H.

Publication type:

Article

No evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodies.

Published in:

Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1501, doi. 10.1007/s00262-007-0295-2

By:

de Beukelaar, Janet W.;
Verjans, Georges M.;
van Norden, Yvette;
Milikan, Johannes C.;
Kraan, Jaco;
Hooijkaas, Herbert;
Sintnicolaas, Kees;
Gratama, Jan W.;
Sillevis Smitt, Peter A.

Publication type:

Article

Induction of protective immune responses against NXS2 neuroblastoma challenge in mice by immunotherapy with GD2 mimotope vaccine and IL-15 and IL-21 gene delivery.

Published in:

Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1443, doi. 10.1007/s00262-007-0289-0

By:

Kowalczyk, Aleksandra;
Wierzbicki, Andrzej;
Gil, Margaret;
Bambach, Barbara;
Kaneko, Yutaro;
Rokita, Hanna;
Repasky, Elizabeth;
Fenstermaker, Robert;
Brecher, Martin;
Ciesielski, Michael;
Kozbor, Danuta

Publication type:

Article

Role of IL-21 in immune-regulation and tumor immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1323, doi. 10.1007/s00262-007-0326-z

By:

di Carlo, Emma;
de Totero, Daniela;
Piazza, Tiziana;
Fabbi, Marina;
Ferrini, Silvano

Publication type:

Article

Works matching IS 03407004 AND DT 2007 AND VI 56 AND IP 9

Density of DC-LAMP<sup>+</sup> mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor.

Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironment.

A new epitope peptide derived from hepatitis C virus 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLA-A11, -A31, and -A33.

Increase in CD30 ligand/CD153 and TNF-α expressing mast cells in basal cell carcinoma.

Dendritic cells loaded with polyomavirus VP1/VP2Her2 virus-like particles efficiently prevent outgrowth of a Her2/neu expressing tumor.

Adoptive therapy of head and neck squamous cell carcinoma with antibody coated immune cells: a pilot clinical trial.

The Thomsen-Friedenreich disaccharide as antigen for in vivo tumor targeting with multivalent scFvs.

Long-term immunity elicited by antibody–cytokine fusion proteins protects against sequential challenge with murine mammary and colon malignancies.

Development of anti-PAX3 immune responses; a target for cancer immunotherapy.

The combined activation of positive costimulatory signals with modulation of a negative costimulatory signal for the enhancement of vaccine-mediated T-cell responses.

Reciprocal effects of Th1 and Treg cell inducing pathogen-associated immunomodulatory molecules on anti-tumor immunity.

Interleukin 21 therapy increases the density of tumor infiltrating CD8<sup>+ </sup>T cells and inhibits the growth of syngeneic tumors.

Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers.

No evidence for circulating HuD-specific CD8<sup>+</sup> T cells in patients with paraneoplastic neurological syndromes and Hu antibodies.

Induction of protective immune responses against NXS2 neuroblastoma challenge in mice by immunotherapy with GD2 mimotope vaccine and IL-15 and IL-21 gene delivery.

Role of IL-21 in immune-regulation and tumor immunotherapy.